Short answer
Leidos (LDOS) filed its Q4 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Oct 2, 2026. Quarterly revenue was $4.6B (up 3.8% year over year) with net income of $410M.
Q4 2026 key financials · XBRL
- Revenue
- $4.6B
- +3.8% YoY · +1.5% QoQ
- Net income
- $410M
- +11.7% YoY · +15.8% QoQ
- Operating margin
- 12.0%
- EPS (diluted)
- $3.30
- +17.0% YoY · +17.4% QoQ
Source: XBRL data from the Leidos (LDOS) Q4 2026 10-Q on SEC EDGAR. USD.
Leidos Q4 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $4.630B, up 3.6% YoY from $4.469B
- Operating margin 11.9% vs 12.0% YoY, net income $1.104B vs $1.127B
- Homeland best performer: revenue $1.024B, up 32.1%; Health weakest: $1.068B, down 11.7%
- Operating cash flow decreased $188M YoY; investing outflow $48M, financing outflow $549M
- Federal funding secured through December 11, 2026; potential shutdown risk after continuing resolution expiration
Risk Factors
- No material changes to previously disclosed risk factors since the January 2, 2026 Form 10-K
- Carried-forward risks remain Leidos’s principal disclosed risk exposures across regulatory, operational, market, and financial categories
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Leidos quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.